Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlig...
April 30 2020 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that
it will host a conference call on Thursday, May 7th, 2020 at 4:30
p.m. Eastern Time to discuss corporate updates and financial
results for the first quarter ended March 31, 2020.
The call can be accessed by dialing (844) 296-7720 (U.S. and
Canada) or (574) 990-1148 (International) and entering passcode
6168259.
To access the live audio webcast, or the subsequent archived
recording, visit the "Investors and Media - Calendar of Events"
section of the Sunesis website at
http://ir.sunesis.com/events-and-presentations/upcoming-events. The
webcast will be recorded and available for replay on the company's
website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, including its oral non-covalent BTK
inhibitor vecabrutinib and first-in-class PDK1 inhibitor SNS-510.
Vecabrutinib is currently being evaluated in a Phase 1b/2 study in
adults with chronic lymphocytic leukemia and other B-cell
malignancies that have progressed after prior therapies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis
Pharmaceuticals, Inc.
Investor and Media Inquiries: |
|
|
Maeve Conneighton |
|
Par Hyare |
Argot Partners |
|
Sunesis Pharmaceuticals Inc. |
212-600-1902 |
|
650-266- 3784 |
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2023 to Sep 2024